Please see Indications and Important Safety Information, including Boxed Warning, about Visipaque at the bottom of this page. Please also read the full Prescribing Information.

Proven to help a wide range of patients

Every patient case presents a unique clinical scenario. As with any procedure, it is important that the contrast media selection be based on each patient’s medical history, present condition, comorbidities, and reasons for diagnostic assessment. Visipaque may be able to assist in treating these patients. Please see full Prescribing Information before using Visipaque in patients.

Please see Indications and Important Safety Information, including Boxed Warning, about Visipaque at the bottom of this page. Please also read the full Prescribing Information.

Visipaque: The isosmolar contrast agent that has been FDA-approved to enhance CCTA

• Visipaque is a distinct isotonic solution
• Visipaque contains sodium and calcium ratios equivalent to those found in blood

Reference: Visipaque [prescribing information]. Marlborough, MA: GE Healthcare; 2017.